Dr. Daniel Sahm, President of Eurofins Medinet, talks to NGP about meeting the needs of the biopharma drug discovery sector, faster and safer services, and the two new Eurofins labs.
With over 20 years experience, Eurofins Medinet serves the pharmaceutical industry with a fully integrated central laboratory package, including central laboratory testing, anti-infective drug development, microbiology to support clinical trials, bio
Dr. Ian Wilkinson and Dr. Carmel McEniery from Addenbrooke’s Hospital, University of Cambridge UK, explain why non-invasive central blood pressure monitoring is a vital new resource in research, clinical trials and drug therapy management.